Navigation Links
In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
Date:6/17/2008

in rapid adoption of new applications.

Trends Across Three Stages of Innovation

Discovery

In 2002, monoclonal antibodies were the highest achieving innovative technology in terms of discovery, while RNAi-based gene therapy was the least. By 2007, stem cells moved from the middle of the pack to achieving the highest discovery innovation index among the six technologies; RNAi moved up, and monoclonal antibodies moved down to a lower level of innovation. Radiotherapy remained relatively high throughout the index. The remaining technologies were the lowest and were nearly identical in 2007.

Development

Radiotherapy was the highest achieving innovative technology in terms of development from 2002 to 2007. Marked by a more than 80 percent increase in the number of approvals from 18 in 2005 to 33 in 2006, radiotherapy experienced a large spike in development. The remaining technologies were near the minimum value of the index.

Realization

Stem cell and RNAi gene therapy were the highest achieving technology innovations in terms of final product realization. While they lack the maturity to make an immediate impact on the marketplace, both appear to be on the rise. Additionally, realization substantially increased over time for the remaining four technologies. From 2002 to 2007, the realization index increased by 39 percent, 34 percent, 48 percent and 31 percent for targeted therapy, monoclonal antibodies, radiotherapy and drug device combinations, respectively.

"Tracking innovation in the life sciences industry will not only be important to industry leaders and pundits, but also to consumers who are already driving major changes to how health care is delivered, as they seek more personalized options for care," said Paul Keckley, Ph.D., executive director of the Deloitte Center for Health Solutions.

Consumers' interest in life sciences and health care innovations was illustrated by the Deloitte Center for Health
'/>"/>

SOURCE Deloitte
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
5. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
7. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
8. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
9. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
10. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
11. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Baylor Research Institute (BRI) at ... Institute (TGen) in Phoenix, AZ , ... detection and treatments for patients with a broad range of ... to new clinical trials and access to technology to drive ... bench to bedside across Baylor Scott & White ...
(Date:5/21/2015)... YORK , May 21, 2015  Prima Biomed ... company that is striving to become a leader in ... cancer, recently announced that the final CVac data from ... shown a clear trend for a clinically meaningful improvement ... in second remission patients. In the group ...
(Date:5/21/2015)... Patent Offering, The patent’s technology pertains to an ... within a body lumen (open space). Known as ... cost, single-use disposable illumination and camera module (housing). ... and the patent approval was received on January 6, ... the lighting and magnification of the endoscope for different ...
(Date:5/21/2015)... 2015 Veolia’s environmental monitoring technology ... American distribution agreement with VWR to distribute TECTA™ ... more than 160 years of experience, VWR, a ... laboratory and production facilities, has cultivated a value ... services to enable science. Endetec’s TECTA™ B16, ...
Breaking Biology Technology:Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4Correction Continues after Big Move - BrokerBank Securities, Inc. 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... announced that researchers will present data on several inflammatory ... College of Rheumatology, from October 17 to 21, 2009 ... , "Through our research into novel disease pathways involved ... of using scientific excellence to deliver life-changing medicines for ...
... 15 BioInformatics, LLC announces the pending release of ... Research Products in FY2010. The 8.2 billion ... the American Recovery and Reinvestment Act is being earmarked ... and research that spans multiple public and non-profit institutions, ...
... 15 /PRNewswire-Asia-FirstCall/ -- China Integrated,Energy, Inc. (Nasdaq: CBEH ... China, today announced that it intends to offer,subject to ... stock. The Company intends to grant to the underwriters ... the Company,s common stock to,cover over-allotments, if any. , ...
Cached Biology Technology:MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 2MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 3BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3China Integrated Energy, Inc. Announces Eight Million Share Public Follow-On Offering 2China Integrated Energy, Inc. Announces Eight Million Share Public Follow-On Offering 3
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a developer ... helmet producer, announced today that they will expand their ... world,s first bio-sensing cycling helmet and the first joint ... two new colors in order to give cyclists more ... In addition, LifeBEAM and Lazer announced their plan to ...
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... In the animal world, males typically search for their female partners. ... reversalthe females search for males. A new study of ... the Royal Society B co-authored by U of T Mississauga professor ... offer a lot more than just sperm. "In this ...
... defined male or female genitals experience a roller-coaster of emotions, including ... a study in the October issue of the Journal of ... found that they were keen to find a sense of harmony ... as. "The parents we spoke to went through a ...
... from the Walter and Eliza Hall Institute have for ... in parasitic worms that could one day lead to ... and prevalent diseases. Dr Erinna Lee and Dr ... programmed cell death (also called apoptosis) in human cells. ...
Cached Biology News:Sexy snacks 2Parents feel shock, anxiety and the need to protect children with genital ambiguity 2Parents feel shock, anxiety and the need to protect children with genital ambiguity 3Worm 'cell death' discovery could lead to new drugs for deadly parasite 2